1. Home
  2. BC vs TGTX Comparison

BC vs TGTX Comparison

Compare BC & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BC
  • TGTX
  • Stock Information
  • Founded
  • BC 1845
  • TGTX 1993
  • Country
  • BC United States
  • TGTX United States
  • Employees
  • BC N/A
  • TGTX N/A
  • Industry
  • BC Homebuilding
  • TGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BC Consumer Discretionary
  • TGTX Health Care
  • Exchange
  • BC Nasdaq
  • TGTX Nasdaq
  • Market Cap
  • BC 3.6B
  • TGTX 4.2B
  • IPO Year
  • BC N/A
  • TGTX 1995
  • Fundamental
  • Price
  • BC $60.47
  • TGTX $27.12
  • Analyst Decision
  • BC Buy
  • TGTX Strong Buy
  • Analyst Count
  • BC 12
  • TGTX 5
  • Target Price
  • BC $66.42
  • TGTX $40.80
  • AVG Volume (30 Days)
  • BC 998.6K
  • TGTX 2.7M
  • Earning Date
  • BC 07-24-2025
  • TGTX 08-04-2025
  • Dividend Yield
  • BC 2.87%
  • TGTX N/A
  • EPS Growth
  • BC N/A
  • TGTX N/A
  • EPS
  • BC 0.63
  • TGTX 0.36
  • Revenue
  • BC $5,097,000,000.00
  • TGTX $454,069,000.00
  • Revenue This Year
  • BC $0.91
  • TGTX $84.00
  • Revenue Next Year
  • BC $4.86
  • TGTX $39.26
  • P/E Ratio
  • BC $95.37
  • TGTX $74.46
  • Revenue Growth
  • BC N/A
  • TGTX 30.96
  • 52 Week Low
  • BC $41.00
  • TGTX $20.05
  • 52 Week High
  • BC $87.65
  • TGTX $46.48
  • Technical
  • Relative Strength Index (RSI)
  • BC 55.33
  • TGTX 25.83
  • Support Level
  • BC $55.84
  • TGTX $25.28
  • Resistance Level
  • BC $59.68
  • TGTX $28.88
  • Average True Range (ATR)
  • BC 2.13
  • TGTX 1.66
  • MACD
  • BC -0.30
  • TGTX -0.93
  • Stochastic Oscillator
  • BC 72.32
  • TGTX 14.55

About BC Brunswick Corporation

Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns numerous Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

Share on Social Networks: